april newsletter 2014
DESCRIPTION
ÂTRANSCRIPT
News May Issue 2014
In this issue:
You look Fabulous! Promoting a Positive
Body Image Scientific & Medical News
News From The Third World Congress
Putting a spring in your step
Scleroderma
Stene Prize Winner 2014
Turn towards the sun:
Prepare for World
Scleroderma Day
Page 17
The Scleroderma Society is a registered charity: 286736
Hello everyone, and welcome to this Spring issue of
Scleroderma News. The birds are singing, the trees
are laced in beautiful shades of pink, and the sun that
we’ve missed so badly is beginning to show its divine face. Yay!
Spring brings with it an exciting new chapter in my life, as I am set to achieve
QTLS (Qualified Teacher Status) this May. Although I have been teaching for the
past three years, making it official with the achievement of my (third) degree is a
monumental achievement for me. My journey has not been easy, alongside all the
usual teaching related issues, I have had to battle to overcome health problems in
equal measure. Though it has tried, Scleroderma has not beaten me, nor stopped
me from attaining this goal. With this, my message for all of you out there, is:
Fight back, reach for the stars, and don’t let Scleroderma get in your way!
Until next time… Hollie xXx
The Scleroderma Society has
adopted the sunflower to repre-
sent our organisation, sunflower
pin badges are available for a
small donation, to buy one
please contact:
Scleroderma News: Welcome Page 2
Welcome! Spring has sprung!
Hello, and welcome to the second issue of Scleroderma News 2014!
Editor’s Note:
I am writing this piece for our newsletter on April 14th.
There is nothing particularly significant for me about this
date except that it is a glorious day and I am sitting in my
garden. The sky is blue and I have turned my chair towards
the sun.
As I reflect on what I have just said I am reminded that
“turning towards the sun” is the theme for our World Scle-
roderma Awareness day. Amy Baker will tell you more
about our plans this year and how you can get involved later
on in this newsletter.
While I am looking at the sun and I reflect on the Scleroder-
ma Society, I am extremely proud and thankful for all of our
supporters. Whether it is you just saying “hello” or that you
“like” us or “follow” us on our social media sites, or you are
involved as a volunteer or fundraiser, it is fantastic to know
that our “community” is growing and increasing in strength
and energy.
I am also thankful for our small team of staff, Amy Baker
(who works full time and looks after volunteers and fund-
raising), Chloe Kastoryano (who works Mondays and Tues-
days dealing with research awards, leaflets, health profes-
sionals liaison, conference planning and other projects), Amy
Barrick (who works part time Tuesdays to Thursdays and
takes care of the office including memberships, finance and
other administration). They are full of brilliant ideas on how
to improve the way we do things and have a sharp focus on
excellence of service and efficiency, so a good team.
As we leave the wet and grey winter behind, I am also
thankful for the seasons, particularly spring and summer,
when brighter colours paint our landscapes and we feel
more motivated. So let us all join in and have some fun for
Scleroderma Awareness weekend 27th to 29th June and “Be
Bright! Be Blue!” for the Scleroderma Society.
I look forward to seeing you all at our AGM and conference
on July 19th.
Best Wishes
Helena
Society News The Latest News - Spring 2014
A Local Group Meeting is
Proposed: Wales / Cardiff
Belinda Thomson is hoping to set a
date for a get together, possibly the
middle of September if anyone is in-
terested in arranging this, please can
they email her directly at the follow-
ing email address: belinda@scleroder
masociety.co.uk.
She says: “At the moment I am think-
ing of around September 18th so
hopefully all holidays will be done and
children and grandchildren will be
back at school.”
Group News From Lancashire
Above is a lovely photo sent in by Sheila Procter of ‘the Lancashire Lasses.’ The girl’s last meeting took place at Sycamore
farm in Burnley. Their next meeting is on Monday 19th May, at 12pm and will also be at held at Sycamore Farm.
For more information contact Sheila using the details featured on our Notice Board page.
West Midlands Group News:
The West Midlands support group held
its first face to face meeting on Thursday
27th March in Birmingham. We enjoyed
a drink whilst sharing experiences of
living with Scleroderma and many good
tips were passed on!
Jane Beach said: “We were absolutely
delighted to be joined by Liz and Steve
from the society and to hear more about
their important work.”
A further West Midlands get together
has been booked for 12th June at 1pm in
Cafe Zest on the second floor of House
of Fraser Birmingham.
All welcome!
Scleroderma News: News Page 3
The Challenge of Disfigurement:
Changing Faces – Who we are and what we do By Deborah Mechaneck,
Regional Officer, East and South East
Over one million people in the UK have conditions, scarring or marks that affect the ap-
pearance of their face or body. Other people’s reactions to their appearance can make
their experience very difficult. They often face staring, intrusive questions, teasing, prejudice
and discrimination. Everyday situations like walking down the street, making friends, using
public transport and applying for jobs can be daunting and overwhelming.
“It wasn’t being in hospital that scared me most.
It was walking down the street afterwards. People
stared at me, called me names or crossed over to avoid
me. I could tell they were embarrassed but their reac-
tions really upset me. I felt so lonely and it was easier
not to go out.”
- Quote from a Changing Faces supporter
One of the most difficult problems someone with a disfig-
urement has to face is the assumptions people make about
them. Three common assumptions that people make are:
1. People with an unusual appearance lead second rate
lives – good looks are believed to be the key to suc-
cess;
2. People with disfigurements are ‘different’, ‘abnormal’
or as in horror films even ‘scary’ or ‘nasty’;
3. People can, and should, get their condition ‘fixed’ by
a surgeon.
Such thinking and assumptions can have a negative impact
on people’s lives and lead to prejudice and discrimination.
Changing Faces is the UK’s leading charity supporting and
representing people with disfigurement and enabling every-
one, whether directly affected or not, to face disfigurement
with confidence. The charity’s work involves: Providing in-
formation, advice and support, to individuals, parents and
teachers, both practical and emotional directly through our
Changing Faces Practitioners or through a wide range of
self-help resources. Offering staff training and consultancy
for professionals and policy-makers to help create fair and
inclusive environments. Campaigning for social change
through promoting a society in which people are treated
fairly and equally. Providing a Skin Camouflage Service, an
important addition to the care that we provide.
What is the Skin Camouflage Service and how does it work?
For someone living with scarring or a skin condition that
affects their appearance and confidence, specialist camou-
flage products offer a way to cope. The service helps indi-
viduals to regain self-confidence and independence. Chang-
ing Faces’ regional officer Deborah Mechaneck, explains
how the service works. “Our trained practitioners select
the best colour match for each person’s skin tone. They
then teach clients how to apply the camouflage creams to
improve the appearance of the affected areas. These creams
can provide effective waterproof cover for a wide number
of skin conditions including birthmarks, psoriasis,
vitiligo and those that cause scarring.”
Scleroderma News: Positive Body Image Special Page 4
Scleroderma News: Positive Body Image Special Page 5
There is no charge for the consultation. However, Chang-
ing Faces is a charity and the Skin Camouflage Service
relies on donations from the public. Deborah says: “It
costs us around £50 to provide each consultation so do-
nations are always welcome to help us continue this and
other services.” The service is available to anyone who
would like to learn how to camouflage a scar or skin con-
dition and is suitable for men, women and children of all
ages and ethnicities.
Deborah adds: “After the initial consultation, clients are
given an advice leaflet to take away with them to remind
them of how the process works. It includes information
about how to use a moisturiser, barrier cream, sunscreen
or medical preparation, prior to applying camouflage cov-
er, which may be relevant to people with scleroderma.”
The Skin Camouflage Service helps over 5,000 people
every year. Deborah has sat through over 30 Skin Cam-
ouflage consultations herself and has seen first-hand the
difference it makes to people’s lives. Some of the follow-
ing quotes demonstrate how beneficial the service is:
“I don’t use skin camouflage every day, but when I’m meeting
someone for the first time it stops vitiligo being a distraction”
“I know the scarring won’t go away but now I can just be my-
self again”
“When I look in the mirror without it, all I see is redness. As
soon as the make-up’s on, I feel so confident and can just get
on with my life” – service user with rosacea
“My volunteer was absolutely lovely, a pleasure to be around.
Very helpful and patient and showed me great products and
how to use them”
“When Changing Faces came to the Society AGM & confer-
ence last year, their stand looked very interesting & I strolled
over for a closer look. Along with hundreds of others, I'm sure,
I have long hated my reduced, furrowed lips, and avoided lip-
stick for years. I was persuaded, however, to give it a try and
ended up choosing quite a dark
red lip liner just to see what it
would look like; expecting to re-
move it immediately! It was cer-
tainly rather dark , but applied
outside the lip edges and filled in,
I suddenly had lips again and the
general feedback was positive. I
have used a quieter colour since.
It takes a bit of time and care,
but is well worth the effort.” - Liz
Holloway
For more information visit:
www.changingfaces.org.uk
One of the most popu-
lar reasons to have per-
manent make up today
would be to eliminate
the daily chore of apply-
ing your usual brow, eye
or lip make up. Fair,
sparse, or uneven eye-
brows can be totally
transformed into beauti-
fully natural and perfect-
ly defined brows, eyes
can be made to look
bigger, brighter and nat-
urally made up and lips
can be perfected with a
lovely hue of colour,
making them look natu-
rally more even and
fuller if desired.
Permanent make up is the art of applying coloured pigments
into the upper layer of the dermis (skin) to enhance your
appearance. Promoted by doctors and beauty journalists
this treatment is a hygienic and safe beauty essential for
those wanting to look their best.
Joanna Twyman has been specialising in the art of perma-
nent make up since 2001.
With a vast array of colours available Joanna uses her expe-
rience and knowledge to custom blend the pigments to
each individual skin tone. The pigments used are non reac-
tive, fragrance free with no emollients added. The results of
the treatment can be a subtle or dramatic as you wish.
For some people this is a total
vanity treat but permanent
make up isn't always about van-
ity alone, for others it enhances
confidence and femininity, espe-
cially when an individual has
been affected by cancer, ill
health or alopecia.
If you would like anymore
Information contact Joanna on
01702 230356 / 07733334665,
www.joannatwyman.co.uk.
The Beauty of
Permanent Make Up
By Joanna Twyman
‘Who are you?’
‘Where did Lynn go?’
These questions consumed me every
time I looked in the mirror after being
diagnosed with Diffuse Scleroderma.
How did I initially cope psychological-
ly and emotionally, having to face the
world as my facial features started to
dramatically change as I morphed into
what is medically known as Mauskopf
(mousehead?) These changes included
thin, pursed lips, a pinched nose and
thick shiny taut skin. My eyelashes and
eyebrows became sparser by the day,
my hair thinned and, to top it all, my
hands and fingers started to curl.
Living with Diffuse Scleroderma in a world where people
are appearance conscious is not easy. However, in this day
and age I am lucky that there are beauty aids readily availa-
ble, such as hair extensions, which help to lift my self-
confidence when I step out.
My personal approach to Diffuse Scleroderma might help
someone who is also diagnosed with it.
Look for a positive. I have no wrinkles
due to the overproduction of collagen.
Always put in the extra time and effort
to look your best without compromis-
ing your health. For example I wear
layered under garments to keep warm
and I never leave my house without
applying makeup, even if it's just draw-
ing in my eyebrows and adding a slick
of blusher. Make up can make a big
difference.
Dress up for special occasions. Despite
needing assistance sometimes, due to
restrictions with flexibility and curled
fingers, I will still make a point of wear-
ing a glamorous outfit, accessorized
with jewellery and get my hair done.
Take the opportunity to use procedures that will improve
your looks. I had laser treatment to my face to help control
the Telangiectasia (red spider veins). I also had some fat
cells transferred to my face, which has given more mobility
to my face and minimized my mask-like appearance.
Don’t hide, no one is perfect. NEVER GIVE UP!
Scleroderma News: Positive Body Image Special Page 6
Fight Scleroderma the ‘Lynn’ Way
Inspirational Lynn shares her top beauty tips
Celebrating Easter
...Because it’s not all
about chocolate! Many of our members have been organising fundraisers this Easter, just like Debbie Jardine, who organised an Easter coffee morning to raise funds in memory of Robert Barrow.
Debbie organised a range of activities to raise as much mon-ey as possible for the society, with a raffle, cake sale and Easter egg decoration competition. Debbie said “the kind generosity of our customers once again made our Easter Coffee Morning a great success. All monies collected this year were in memory of Bob Barrow a customer and close family friend. A fun time was had by all the children and adults alike”. The Easter coffee morning raised a fantastic £300 for the society.
If you would like to organise an event just like Debbie then get in touch with Amy today:
Scleroderma News: Fundraising Page 7
DO YOU HAVE A FUNDRAISING EVENT IN THE PIPELINE?
PERHAPS YOU HAVE A FUNDRAISING SUCCESS STORY THAT YOU
WOULD LIKE TO SHARE WITH READERS OF SCLERODERMA NEWS?
We’d love to hear from you! Get in touch with Amy Baker, at:
[email protected] and you could be featured on this page!
In loving memory of Dave Willis
London 2 Brighton Challenge
By Noreen Walsh, who will be 52 in a couple of weeks
when she completes the challenge…
“London 2Brighton is an extreme challenge that you can
run, jog or walk. It covers 100km, 62 miles in real money,
and you are given 30 hours to complete. I have done the
challenge twice before for another charity and raised a lot
of money. I think that to raise money you need to do
something that people feel is a bit strange or something
they would not do themselves. I run a10K for charity and
get nowhere near the same response as this challenge. It
is not only a physical challenge but a mental one! By the
time you complete half of your challenge you are physical-
ly and mentally exhausted but the camaraderie keeps you
going. It is so well organised you feel safe all the way.
My friend Dave Willis died of complications related to
scleroderma and his anniversary will be in May this year.
What a better way to pay tribute to the struggle that
those with this cruel disease face than to push yourself to
the limit! I am not going to tell anyone that it is easy! If
you can walk you can complete this challenge. (Blisters
never killed anyone).
I have completed this challenge before in 27hrs but
hope to go a bit quicker this year. However speed is not
the issue! I am not 18 any more and am not doing it to set
any records. I want to do it to raise money for the sclero-
derma society in memory of Dave.”
Support Noreen today: http://uk.virginmoneygiving.com/
NoreenWalsh.
Our Star, Daniel Thomson Daniel lost his Grandma; Dianne Roe-
buck to Scleroderma on 13th February
2013 aged 69.
Joanne Thomson (Daniel’s Mum) said:
“Daniel did not want the anniversary
to be a sad day and wanted to do
something funny to raise money and
make us all smile. He asked me if he
could shave his head and raise money
for Scleroderma. For a self-conscious
12-year-old boy, I thought this was a
very brave and wonderful thing to do,
so said yes straight away.
We approached his school to
ask for support and they
agreed they would let him do
this at school and encourage the chil-
dren to support and sponsor him.
Daniel has not only raised £430 with
money still coming in, he has also done
a fantastic job in raising awareness of
the condition. The local newspaper is
featuring his story and his friends at
school posted pictures on Facebook
explaining what he has done, some of
which have had over 1000 likes.”
Spring’s Fundraising Stars
What is a dry athlete?
A Dry athlete is basically someone
who gives up alcohol for a period of
time! In my case, 2 months. I was on
average drinking around 25 pints of
beer a week and the longest period of
time I experienced without
alcohol before was a week. I am
particularly proud to achieve 2
months.
Why did you choose this fund-
raiser to support the Sclero-
d e r m a S o c i e t y ?
I chose the Scleroderma Socie-
ty because Scleroderma and
Raynaud’s are currently affect-
ing my partner’s mum. I was deter-
mined to raise money for this cause
because she continues to battle on and
keep smiling and is a fantastic inspira-
tion for us all. I had an incentive to
lose weight as well (currently 2 stone
lost) and thought the idea of doing a
dryathlon for a cause particularly close
to my heart would be a good idea! The
whole experience has changed my life.
How much money did you raise?
In total, I raised £800. My initial target
was £250 but I raised 3 times more!
What would you
say to others
considering fund-
raising for the
Society?
I would definitely
encourage peo-
ple to consider
fundraising for a
fantastic charity. I received a letter and
certificate thanking me for my efforts
and the official Facebook page con-
stantly promoted my just giving page in
order to raise as much as possible.
Thank You...
Company Giving
Thank you to David Grieve for nomi-
nating us to be included in his compa-
ny Lands’ End’s Giving and Sharing
Scheme that raised £246.00 for the
society.
If your company has a giving
scheme please consider nominat-
ing the Scleroderma Society.
Scleroderma News: Fundraising Page 8
Interview with Dryathlon
Champion Chris Jones
Waitrose fundraising Success Story... On the 9th April we were invited to Waitrose in Newport to hold an awareness and fundraising event. This event was held in memory
of Victoria Garratt, the former Branch Manager, who passed away a year ago, aged 33 from complications relating to scleroderma.
Waitrose were wonderful on the day
and their generosity showed how
much Victoria meant to them. Wait-
rose supplied us with three wonderful
hampers to be raffled and our volun-
teers brought plants and books to
sell. We had a range of informative
literature about scleroderma.
It was a really successful day, as we
had a constant stream of customers
wanting plants, books, raffle tickets or
just to donate to us. All the volun-
teers were great, speaking about why
we were holding the event and ex-
plaining scleroderma and how the
disease affects them.
On the day we raised a fabulous £420.33
for the society and raised a huge amount of awareness
amongst the general public. Jennifer Ames said: “Gordon and
I enjoyed the time we spent there. Yes it was hard work but
the tiredness was more than made up for by some lovely
people we met, many were interested and caring. Some
asked why they had not heard of Scleroderma before though
they had heard of Lupus, and found it hard to believe a suf-
ferer could be affected in so many ways. I was selling plants
and books I gave away a pack of snowdrops and a parsley
plant, and the recipients, a young couple and an elderly lady,
were so pleased they beamed from ear to ear. I asked the
elderly lady to remember us when the Snowdrops flower
next year, I hope that she is still around. It has been a hard
winter and an early spring for us but we certainly got a lift
when total strangers showed they care.”
Thank you to all of the volunteers who made the day
possible; Jennifer and Gordon Ames, Jacqueline Cox
and Helen Mason and to the Waitrose Management;
Andrew Yip, Pam Edwards and Tim Fielding for their
support. We are proud to be working in partnership
with this store and are planning another event to
celebrate World Scleroderma Day in June.
If you live close to Waitrose, Newport and would
like to be involved with this event please get in touch
with Amy, [email protected].
Photos: Top: Andrew Yip, Pam Edwards, and Amy Baker.
Middle: volunteers fundraising on the day and bottom:
Tim Fielding, Jacqueline Cox and Jennifer Ames.
Scleroderma News: Fundraising Page 9
Dancing down the Road of Life,
winning essay of “Vision 2043 –
my ideal world for people with a
rheumatic or musculoskeletal
disease”
I imagine the road of my childhood
lying before me, feeling the pavement
beneath my bare feet, letting myself
follow it, losing myself in the feelings
and thoughts of bygone days.
I take the first tentative steps and let
my thoughts carry me off to a time
when the wind blew in my hair. How
my tiny little feet ran and ran, intoxi-
cated with the speed, an intoxication
that spread to my stomach, forcing
from me squeal upon squeal of childish
delight.
I remember carefree summer evenings
with dew between my toes, splashing
about in water and exploring treetops,
looking for the next foothold. Those
little feet carried me high and low. The
world was mine.
The feeling of freedom grows in me,
and fearlessly I take the next step
along the road of my childhood; this
step brings memories of a youth filled
with pain, recollections of a slow, test-
ing journey. Remembering how the
freedom of childhood turned into a
bodily imprisonment, dwelling on the
pain, letting it enter me, allowing my-
self to be overwhelmed by it, wallow-
ing in it.
The next step is a huge battle. It is a
battle against my own desire simply to
give up – to give up and crawl into a
safe hiding place away from the little
needles that now cover the pavement.
Yet the battle has to be fought – not
just the battle against the disease, but
also the battle for the right to exist in
a competitive world where illness is
unwelcome.
Those stubborn feet, that stubborn
spirit, take me several steps further.
Memories of trying out medicines that
don’t work or have terrible side ef-
fects disturb me and beg me to carry
on fighting. The little needles are still
spread before my feet, beckoning,
taunting; and feelings of powerlessness
ride roughshod over my fighting spirit.
One mighty step more and I look back
down the road of my childhood, my
youth and my adulthood. I see my life
as I have lived it up until now. I turn
and open the door to the life to which
the battle has led me – not just my
battle, but the researchers’ battle, the
doctors’ battle… The battle for the
bearable, dignified, wonderful life of-
fered in 2043.
My feet stride stubbornly, greedily,
further on into life, and many doors
open along the way. The battle has
ceased because my body is now able
to work, to live. The researchers have
found a way to tell which medicine will
work for which person, so life does
not revolve around spending time and
resources trying out different medi-
cines. Types of medicine have been
found that work gently, but are so
effective that the disease is sup-
pressed, to the point that my feet now
skip along without any fear of needles
on the pavement.
My body is at peace, and the devastat-
ing exhaustion gradually leaves me as
my feet dance along. The taunting nee-
dles have been swept aside and if ever
they do creep back onto parts of the
pavement, it is only for a little while
because pain relief has become so
much more holistic and effective.
In this life, we are not given
a diagnosis to be hung up as
And The Winner is...
Marinka Stein Due Sørensen, from Denmark
wins the 2014 Stene Prize
“I’m originally from Ribe – an old and exciting city with a lot of history. I
now live in the countryside near Silkeborg in one of the most beautiful
parts of Denmark. I love to visit the forest or to walk by the sea. I spend
most of my time with my family. I have been married to my husband Mi-
chael for 12 years. We have two lovely sons: Valdemar who is eight years
old and Storm who is three. I am currently unemployed because of my
illness, but I used to work as a teacher. I am educated to teach literature,
history, biology and arts. I paint pictures and I love art in all forms. I read a
lot and I enjoy being told a good story, whether it is a book or a film. I
work out three times a week to keep my body fit – it also has a good effect
in terms of my illness. In the summertime, my family and I visit different
museums and marketplaces, where we re-enact the life of the Vikings. It is
a hobby we can share as a family and we have a lot of friends in the ’Viking
society‘ from all over Europe.”
Scleroderma News: Stene Prize Winner Page 10
Scleroderma News: Competition Page 11
[Continued…]
a warning sign; we get a diagnosis but
at the same time we are told that we
can be perfectly healthy, happy and
active people who have rheumatism.
In this life, a person with rheumatism
is regarded as a strong person – a
person who is capable and willing.
Knowledge and shared humanity give
us the desire to find our place in life,
to discover what we can do better
than anyone else. If our bodies some-
times suffer a day’s sickness, there is
an effective safety net that catches us,
supports us and helps us. No more
dreams will be shattered on that nee-
dle-strewn pavement!
I stand in this life and let it embrace
me, relishing the knowledge of how
the battle has been won with the
help of research, skill, understanding,
humanity and those ever stubborn
feet.
While I bask in this embrace, I see
my two lovely sons striding along the
pavement, their father between them
holding their hands. They are smiling
and laughing, and behind their smiles
there is no worry that something
might happen that will hurt their
mother. They are just genuine, joyful
smiles. They let go of their father’s
hands, and their little feet carry
them, wind-blown and squealing into
my arms where they are met by a
dance and a song of life.
This is my journey, but also that of
many other people. My hope and my
dream is that, like everyone else who
has a rheumatic disease, I will be able
to stand in this life in 2043 and reap
the rewards of all the battles that
have been so well fought!
By Marinka Stein Due Sørensen
This year we are looking to our mem-
bers to produce an artistic piece to
symbolize what this years World
Scleroderma Day theme means to
you.
The theme ‘Turning toward the Sun’
was inspired by Paul Klee’s, 1933 sun-
flower piece.
To take part in this competition all
you need to do is send in your art-
work by Friday 20th June. An external
panel will then judge all the work and
decide upon a winner.
The winning artwork will become the
cover for the next Scleroderma
News.
Artwork will be displayed at the
World Scleroderma Day Celebration
on the 3rd July and then at our Annual
Conference on the 19th July in Lon-
don.
Send your artwork to: Art Competi-
tion, The Scleroderma Society, Bride
House, 18-20 Bride Lane, EC4Y 8EE.
Please note we will be unable to return
artwork unless a stamped addressed
envelope or container is provided.
Inspired By Paul Klee
Art Competition
^ Klee’s portrayal of the Sunflower is a work of art
Scleroderma News: World Congress Feature Page 12
The World Congress is an oppor-
tunity for scientists, clinicians, allied
health professionals and others with
an interest in systemic sclerosis, in-
cluding people with scleroderma
themselves, to come together and
find out about the latest updates and
news from across the research
world. The patient arm of the con-
gress enables people with scleroder-
ma and their friends and families to
find out more about the condition,
hearing from leading experts across
the world.
The congress opened with a
ceremony including a welcome from
Alexandra Klee, the patron of the
World Scleroderma Foundation. An-
nie Kennedy, President of FESCA
(Federation of European Scleroderma
Associations, an umbrella group of
patient support organisations in Eu-
rope), gave a thought-provoking
speech from the patient’s perspec-
tive. The opening scientific lectures
then gave an overview of the cutting
edge in scleroderma research and
what’s new in that field over the last
two years. Thursday also saw a
round-table networking session for
leaders of patient groups where the
discussion centred on the main chal-
lenges faced by the patient organisa-
tions in different countries. While
some countries have strong back-
grounds in fundraising, this is very
much a cultural phenomenon some-
what localised to certain countries
such as the UK and the US, where
we have a culture of partaking in
sponsored events and other activities
to raise funds for charitable causes.
We are lucky this exists in the UK, as
the majority of our European and
global counterparts don’t enjoy such
a proactive fundraising culture, as the
representatives from patient groups
in other countries explained to us,
thus making finding income a lot
harder for them. Other issues dis-
cussed around the table were prob-
lems faced by patient groups in some
countries where scleroderma is not
recognised as a rare disease and as
such does not receive sufficient fund-
ing. In other countries, access to, or
even existence of, scleroderma clinics
was a real concern.
Now let’s move on the med-
ical sessions, where the programme
kicked off with Professor J. van Laar’s
talk entitled, “Why did I get sclero-
derma and will I be cured?”. Profes-
sor van Laar is Professor and Chair,
Department of Rheumatology & Clin-
ical Immunology, University Medical
Center Utrecht, the Netherlands.
The questions he posed were:
Why did I get
scleroderma? And
will it be cured?
His answer to both questions was:
The good news is we have an answer!
- The bad news is the answer is that
we don’t know! Prof. van Laar de-
scribed the scleroderma puzzle as
consisting of many questions involving
fibrosis, fibroblasts, growth factors,
skin, genes, immune cells, environ-
ment, autoantibodies, and more. He
explained scleroderma is thought to
be an autoimmune disease, and that
autoimmune diseases arise when the
immune system “goes awry”. He de-
scribed the immune system as being
like an “orchestra of like-minded mu-
sicians. Practice and fine-
The Third World Congress on
Systemic Sclerosis, Rome 2014
This February we returned to Italy, to the capital city of
Rome, following on from the inaugural congress in Florence in
2010 and the second in Madrid in 2012. Susie Hoare reports...
Photo: Professor J. Van Laar speaks at the World Congress
tuning are everything.”
Prof. v Laar highlighted the
following as evidence that scleroder-
ma i s an au to immune d i s -
ease:Scleroderma autoantibodies can
be detected in the blood of (most but
not all) scleroderma patients;
Limited and diffuse scleroderma are
associated with different autoantibod-
ies; Immune cells in scleroderma are
abnormally activated; Studies on
DNA from scleroderma patients have
revealed genetic factors involved in
immune responses.
He went on to look at some
very interesting information regarding
lessons learned from twin studies:
studies on identical twins have actual-
ly shown a low concordance for scle-
roderma, indicating scleroderma can-
not be explained by genetic factors
alone. When one identical twin has
scleroderma, it is rare for the other
twin to also have scleroderma.
Prof . v Laar then spoke about the
risk factors for increasing the risk of
developing scleroderma: Genes
(mostly related to immune function);
Female gender; Possibly chemicals (in
some situations). The risk factors
influencing the severity of scleroder-
ma: Male gender; Higher age; Smok-
ing.
Prof . v Laar closed by ex-
plaining, although we don’t yet know
the cause and the cure, we’re getting
there thanks to: Promising results
from recent clinical trials (ASTIS);
International collaboration between
patients, scientists and doctors
(EUSTAR, World Congress, etc);
Rapid spread of news via the Internet.
Continuing on the next international
speaker, we heard Professor Distler
of University Hospital, Zurich, Swit-
zerland, speak about why breathing is
so difficult for some people with scle-
roderma.
In short, it is multifactorial,
with many possible reasons. The most
frequent in systemic sclerosis are lung
fibrosis and pulmonary arterial hyper-
tension, leading to impaired gas ex-
change. Professor Distler also ex-
plained that problems can be caused
by tight skin, as breathing requires
elastic skin so the chest can expand
to inhale. If you have tight skin, this
can limit the amount you can expand
your chest and makes breathing hard.
Lung fibrosis, which occurs in some
people with systemic scleroderma,
causes scar tissue formation in the
lungs. Having scar tissue in the lungs
impairs the ability of the lungs to ex-
change gas efficiently, leaving people
short of breath.
Pulmonary hypertension,
which is raised blood pressure within
the pulmonary arteries (the blood
vessels that supply the lungs), also
causes impaired gas exchange, leaving
people breathless or finding breathing
hard. Professor Distler showed us the
“line-up” for a typical day of testing
for patients at his clinic:
9 am Blood tests, capillaroscopy
10 am Echocardiography
11 am Cardiac MRI
1 pm CT lungs
2 pm Occupational therapy
3 pm Lung function, 6 MWD
4 pm EKG
5 pm Consultation with doctor
The goal of testing for lung disease is
early detection, leading to early treat-
ment and better outcome. The causes
of difficulties in breathing are multifac-
torial, and if someone has problems
with breathing, all the possible causes
should be examined.
Following on from Professor
Distler’s talk, we then heard about
breathing problems from a
patient’s perspective, and
Scleroderma News: World Congress Feature Page 13
Photos: Above Professor O. Distler and below Professor C. Denton.
Scleroderma News: World Congress Feature Page 14
[Continued…]
and what you can do to help yourself
and make life easier. The presenta-
tion was given by Kim Fligelstone
from the UK, with input from a range
of sources including people with scle-
roderma, doctors, and medical asso-
ciations supporting people with lung
conditions.
Kim gave us a vast array of tips pro-
vided by people with difficulties
breathing, and this is a selection of
some of those:
Conserve your energy:
Put everything you need within your
reach, cupboards and wardrobes you
don’t have to bend for, oOrganise
yourself and keep items in the same
place
At home:
Avoid bending, lifting or overstretch-
ing. Use light vacuum cleaner and
irons, sit down where possible e.g.
ironing, food preparation. Use a
kitchen timer, a tray or trolley.
Washing and dressing:
Put on bathrobe after washing / use
separate towels, avoid bending for-
ward drying feet, have seats every-
where e.g. - in shower, by sink, by
mirror. Wear loose clothing so it is
easier to dress yourself. Cut sock
elastic and use a long-handled shoe
horn.
Bedroom:
Get up slowly, relax. Use lighter du-
vets. Two single mattresses on dou-
ble bed. Use extra pillows to raise
head. Put oxygen concentrator out-
side bedroom.
Going out – plan ahead:
Avoid rushing: plan journey time.
Walk at your pace and consider a
walking stick. Consider a wheelchair
too. Spread shopping into lots of
bags! Keep spare medicines in car
and with you when travelling.
If you are interested in reading the
full set of tips from this presentation,
you can download this presentation
as well all the others from the con-
gress, from the following link on the
FESCA website: http://www.fesca-
s c l e r o d e r m a . e u / w o r d p r e s s / ?
page_id=368
In the next issues of Scleroderma
News, we’ll continue with more de-
tailed reports from the other presen-
tations. We hope you look forward
to hearing about the following topics:
Gastrointestinal problems that peo-
ple with scleroderma may experi-
ence, Dr. Janet Pope of the Universi-
ty of Western Ontario. Tips for help-
ing yourself live with GI problems,
useful equipment and tips for day to
day life with scleroderma. The New
ACR-EULAR systemic sclerosis clas-
sification criteria from Dr. Frank van
den Hoogen, Radboud University
Medical Centre and St Maartensclin-
ic, Nijmegen, The Netherlands. Taking care of your ulcers, Barbara
Gemmell, St. Vincent’s Hospital, Mel-
bourne. Carers and family member,
Robyn Syms, President, Scleroderma
Australia. Fatigue and how to deal
with it, Dr. Janet Poole, Professor in
the Occupational Therapy Graduate
Program, University of New Mexico.
Photos: Above and below Professionals, speakers and patients from around the world gather at the World Congress.
Why Not Attend Our
Educational Event?
On the 3rd July , you are invited to
join us at the Royal National Hospital
for Rheumatic Diseases, Bath, to cele-
brate World Scleroderma Day
through an exciting educational
event.
The day will be split
with a patient focused
event in the morning
looking at ‘what you
can do to help your
Raynaud’s and Scle-
roderma? ’ and
‘current and future
treatment options for
scleroderma’.
The afternoon will be clini-
cian/AHP focused providing an
overview on pathogenesis, clinical
features and practical management of
Raynaud’s phenomenon and systemic
sclerosis.
For further information and to book
your place visit: www.scleroderma
society.co.uk/WSDCelebration2.php
In partnership with the Raynaud’s and
Scleroderma Association
Scleroderma News: World Scleroderma Day Page 15
27th June – 29th June:
This year support us by wearing your
brightest blue for World Scleroderma
Day. You can raise funds in your
workplace by getting your colleagues
to wear their brightest blue and do-
nate £1 or more to the Scleroderma
Society UK.
You can host a bright blue event! Why
not get out in the sunshine and have a
picnic or organise a local walk?
Order your free fundraising pack to-
day by email:
We would love to see pictures of you
“Being Bright, Being Blue” to feature
in our website gallery and in our
newsletter. Please send all pictures to
To find out more about how you can
be involved in this event vis-
it:ww.sclerodermasociety.co.uk/
BeBrightBeBlue2.php
Be Bright and Blue to
Support Scleroderma
Preparing For World Scleroderma Day 29th June 2014
Scleroderma News: Scientific & Medical Page 16
One of the main problems in sclero-
derma and systemic sclerosis, at the
tissue and cell level, is fibrosis. This is
an out of control wound healing pro-
cess causing excessive scar formation
in e.g. the skin and lungs, leading to
the tightness of the skin, reduced
organ function and life threatening
consequences in severe cases. At the
Royal Brompton Hospital, one of our
research goals is to study in detail the
key effector cells in fibrosis, fibro-
blasts, to understand why, in disease
circumstances, they behave in an un-
controlled manner. We want to iden-
tify the key regulators of this behav-
iour, and find compounds (drugs)
which can interfere with these to
slow down disease progression. De-
scribed here is an example of the
work we undertake.
The shape of the cell, and
certain functions like movement, are
supported and regulated by a dynamic
mesh of thin stiff fibres spanning the
inside of the cells, forming a part of
the so called cell cytoskeleton. These
fibres are made of a group of proteins
called actins (stained red in the pic-
ture). Cell movement, for example, is
controlled by these fibres growing at
one end of the cell, causing a protru-
sion, and at the same time being dis-
mantled at the opposite end, causing
that end of the cell to retract, or
shrink. This process is also helped by
specific proteins on the outside of the
cells, grabbing on to and holding the
surrounding tissue at the front end,
and at the same time letting go at the
back. When specific types of cells,
including fibroblasts, are exposed to
certain types of stress, e.g. excessive
pulling stretch, pressure, or are ex-
posed to biological substances, e.g. in
response to injury, they adapt by bun-
dling the thin actin fibres together to
form thick rod-like fibres, also called
stress fibres (red in the picture), in
order to become stronger. A particu-
lar type of actin protein, called alpha-
smooth muscle actin (aSMA), is pro-
duced in fibroblasts exposed to ex-
cessive or prolonged stress (stained
green in the picture). This protein is
normally expressed in smooth muscle
cells, for example making up layers in
our blood vessels. When this type of
actin gets incorporated into actin
fibres in fibroblasts (in the pictures,
making the red fibres appear yellow),
the cells can contract like muscles, i.e.
they pull at both ends and become
shorter and thicker – the actin fibres
have become like microscopic rubber
bands. When this occurs, the fibro-
blast is called a myofibroblast (myo
meaning muscle). In smooth muscle
cells in blood vessel walls, such con-
traction causes a narrowing of the
lumen (the middle space where the
blood flows), and the pressure in-
creases inside the vessel. The con-
traction and relaxation of these cells
is a normal process to regulate blood
pressure, but if excessive can cause
problems like high blood pressure
(hypertension). In myofibroblasts, this
contracting property is essential for
wound healing, as it makes the cells
pull the damaged tissue together to
repair and close the wound. During
this process the myofibroblasts will
also secrete factors, which break
down damaged tissue scaffolding ma-
terial (extra cellular matrix, ECM),
like collagen, and produce fresh ECM
to replace and build up the tissue
again. It is when these processes, con-
traction and ECM production, be-
come excessive, we get scar tissue
formation. This pathological condition
in the tissue of organs such as skin or
lung is termed fibrosis. Fibrosis is
primarily caused by either an uncon-
trolled accumulation of fibroblasts/
myofibroblasts in the injured or in-
flamed tissue, or a greater proportion
of fibroblasts developing into myofi-
broblasts, both resulting in excessive
scar formation. At the Royal Bromp-
ton Hospital, London, we are in
search of drugs which can
stop the progression of
Myofibroblasts: How the study of cells can
help find treatments for Scleroderma
By Dr Gisela Lindahl, Royal Brompton Hospital / National Heart & Lung Institute
Photograph taken by Dr Patricia Leoni-Garcia
Dr Mark Porter's Case Notes on
Radio 4 has prompted the question to
the ScSocHelpline on safety of using
Omeprazole and similar medication -
given the new findings.
The question is; If people with Scle-
roderma have been taking these types
of drugs for many years is there cause
for concern and should they stop
taking as suggested to test if they still
need them?
Answer:
Although long term use of proton
pump inhibiting drugs like omeprazole
does have some potential side effects
the benefit of being on these treat-
ments for scleroderma patients gen-
erally outweighs any risk. This is
quite different from the widespread
use of omeprazole in people without
scleroderma. Acid reflux in sclero-
derma can otherwise lead to scarring
or stricture of the oesophagus that
may require surgery or might worsen
lung fibrosis. Nevertheless it is sensi-
ble to have routine blood tests in-
cluding magnesium levels checked,
especially if your doctor is concerned
about possible side effects.
Question: Does anyone know if there
has ever been any research conduct-
ed into the use of artificial sweeten-
ers (aspartame) and Raynauds? I just
saw a comment about it causing auto-
immune issues. I have used artificial
sweetener most of my life and was
just wondering!
Answer:
Aspartame may cause blood vessels
to narrow, like caffeine and some
other chemicals. In theory this could
worsen Raynaud’s phenomenon but
there is no major evidence to support
this and I am not aware of specific
research into this area. Many sub-
stances can make symptoms worse
and if individual sufferers notice this
then they should avoid them but at
present there is no official concern
about aspartame of any other artificial
sweeteners being harmful.
Got a question? Send it in to us and
we will do our best to get it an-
swered for you next issue!
DOC SPOT Chris Denton is a Professor in the Centre for Rheumatology at the
Royal Free Hospital in London and runs the Scleroderma Clinic. He
also has a major research programme that spans both clinical and
laboratory trials related to scleroderma.
Scleroderma News: Scientific & Medical Page 17
[Continued…]
fibrosis and are therefore trying to
identify compounds (drugs) which
can block either of those process-
es, fibroblast accumulation, or so
called fibroblast-to-myofibroblast
differentiation. We use a Carl
Zeiss fluorescence microscope
(kindly funded by the Scleroderma
Society) to study fibroblasts/
myofibroblasts from scleroderma
patients, and can by staining the
cells using specific antibodies and
dyes determine e.g. how many
cells contain the aSMA type of
actin stress fibres. We can then
treat the cells with different com-
pounds to see whether they affect
the number of aSMA containing
cells. We are currently testing a
novel compound, originally devel-
oped for the treatment of cancer,
which appears to have the main
characteristics required also for
combatting fibrosis. Some of our
results were reported at the annu-
al conferences of the American
Thoracic Society and European
Respiratory Society last year.
While we know that extensive
testing over a relatively long peri-
od of time will be required to de-
termine the suitability of this drug
for treatment of fibrosis, and of
course the safe use in patients, we
are at a very exciting early stage of
research into a new potential drug
for scleroderma.
Scleroderma News: Scientific & Medical Page 18
Inside Health has learned that there is
growing concern in some quarters that
we have become too quick to use them –
a problem compounded by the fact that,
once you start the drugs, they can be
difficult to stop. For long- term users,
should we as was suggested stop taking
the medication for six weeks to see if
symptoms disappear, have regular blood
tests for magnesium levels?
Proton pump inhibitors (PPI) have
transformed the treatment of acid
related disorders in gastroenterology
over the last 20 years and are incredi-
bly effective at suppressing acid pro-
duction in the stomach. When they
were initially used we felt that since
they had so few apparent side effects,
we were very relaxed about using
them freely and often for long periods
of time if they were effective. This has
led to PPI prescription numbers being
one of the largest of any drug world
wide and many people end up on
them long term. In the general popu-
lation we know that this is not always
(in fact often not) necessary. Recent
large studies have suggested an in-
creased risk of low magnesium levels,
osteoporosis and an increased risk of
picking up hospital acquired lung and
gastrointestinal infections.
The vast majority of the general pop-
ulation taking PPIs will only need
these for short periods and have no
underlying pathology or disease that
requires long term treatment. In scle-
roderma the situation is however
different. Up to 90% of scleroderma
patients will have oesophageal symp-
toms due to change in gullet motility
and this leads to a high prevalence of
acid and gastric content reflux. Con-
stant uncontrolled reflux can lead to
stricturing (narrowing) in the oesoph-
agus (which makes swallowing worse
and may need dilatation), Barrett’s
oesophagus (a change in the lining of
the oesophagus which can increase
the risk of cancer) and there is in-
creasing evidence that a group of pa-
tients may aspirate/inhale small
amounts of acid which in turn makes
pulmonary fibrosis/scarring worse.
There is still some debate as to
whether all scleroderma patients
should be on a PPI. The UK Sclero-
derma Study Group has recently
looked at this and the treatment of
other associated gastrointestinal
symptoms and the consensus was
that a PPI should be used in all those
that are symptomatic since any small
risks of long-term use are outweighed
by the benefits. There will be some
patients that can come off these med-
ications, but the vast majority will
not. Given the current paucity of oth-
er effective treatments and the fact
that surgical intervention is unwise,
we would are very happy to recom-
mend long term use in patients with
scleroderma, with the caveat of
course that we regularly review the
need and dose of all medications.
Omeprazole, Lansoprazole & The Proton
Pump Inhibitor Family
By Dr. C Murray
'Vision 2043' competition 2014: Your Chance to Get Your Hands on €300!
The World Arthritis Day competition
runs until Friday 18 July 2014. Grab
your chance to help to change the
future for people with rheumatic and
musculoskeletal diseases (RMDs) by
entering the 'Vision 2043' competi-
tion. You could win a cash prize.
There will be two winners: The Euro-
pean entry (from a EULAR member
country) which has received the most
online votes., and The Global entry
which has received the most number
of online votes. Winners will each
receive 300 Euro!
The European winner will also win
attendance to the 2014 EULAR Annu-
al European Conference of PARE in
Zagreb, Croatia.
Two runners-up will each receive 50
Euro and up to seven entries will be
chosen by the Vision 2043 jury for
commendation (no cash prize).
Anyone can vote so make sure you
tell your family and friends about your
entry!
See www.worldarthritisday.org/
vision2043 for more
information.
AGM / Annual Conference
This year the Scleroderma Society’s AGM and Annual Confer-
ence will be held on 19th July at the Royal Free, 11- 12:00 and
12:00-16:30 respectively...
Scleroderma News: Annual Conference 2014 Page 19
The Scleroderma Society were at the
British Society for Rheumatology's
annual conference in Liverpool last
week. We jointly shared a stand with
the Raynaud's and Scleroderma Asso-
ciation to raise awareness of the con-
ditions amongst health professionals.
The event provided us with
the opportunity to meet many of the
researchers who are working hard to
fight scleroderma and it's associated
symptoms, and to inform allied health
professionals of the condition and of
the Society. The event also provided
us with the opportunity to meet oth-
er patient organisations whose condi-
tions have associated symptoms of
raynauds and scleroderma - Lupus
UK and Arthritis Care. We look for-
ward to developing these relation-
ships and working closely with them
to assist in supporting you.
We would be delighted for any mem-
bers, patients, carers, health profes-
sionals or individuals with an interest
in Scleroderma to attend.
The theme of the day will be
‘therapies’ and we are pleased to an-
nounce that we will be joined by
Consultant Rheumatologist Professor
Chris Denton, Specialist Registrar for
Rheumatology, Doctor John Pauling,
Professor of Clinical Rheumatology,
Jaap Van Lar and Clinical Nurse Spe-
cialist, Colin Beevor.
In addition to the sessions
we have confirmed an excellent varie-
ty of peripheral activities for the day.
This includes Changing Faces’ skin
camouflage team and the Royal Frees
Therapies Team for complementary
sessions on skin care. Scleroderma
Society’s Helpline team will also be
present to answer any questions and
meet the members. As-per we will
also be holding our raffle with our
best-ever selection of prizes!
We hope you are able to
join what will be a thoroughly enjoya-
ble and thought provoking day.
To view
the full programme
and to register your place
please visit: http://www.scleroderma
society.co.uk/AGMampAnnual
Conference2.php or complete and
post the form attached.
British Society for Rheumatology:
Annual Conference 2014
“I began my role as Project Coordinator with the Scleroderma Society in
January. I have thoroughly enjoyed my time so far with the Society; the
Trustees and staff are extremely encouraging and supportive and it’s been a
joy to see how highly involved the members are.
I also work part time with the Arthritis and Musculoskeletal Alli-
ance (ARMA) in the same role. ARMA is an umbrella organisation for mus-
culoskeletal organisations and this is how I learned about scleroderma and
the Society, in addition to working in the same building as them.
The Society will be holding its AGM and Annual Conference at the
Royal Free on the 19th July. I have been working closely with Professor
Chris Denton to finalise the programme and to ensure the day is as in-
formative as possible. We will also be joined by Changing Faces’ camouflage
team and the Royal Frees Therapies
Team for complementary sessions on
skin care and hand massages.
I look forward to meeting
many of you on what is promised to be
an extremely informative and enjoyable
day.”
Congratulations to Amy!
We are extremely
pleased to announce that
Amy, our Fundraiser, was
awarded her Gold Duke
of Edinburgh award by
HRH The Earl of Wessex
at St James¹s Palace this
month.
To achieve the award
Amy undertook a four-day and three-
night expedition in the Black Mountains,
where her group had to survive in ‘wild
country¹ and navigate their way to their
final pick up point.
Amy has voluntarily been undertaking this
physically demanding challenge over the
past year to gain this award and we are
delighted with her achievement!
Can you solve the Sclero-crisscross?
Focusing on: Scleroderma
Medications and Treatment Options
Immunosuppressive Therapy
The following is an excerpt from chapter 23 of Systemic Sclerosis, 2nd Edition written by Dr. Laura Hummers and Dr. Fred Wigley:
‘The most popular approach to controlling the inflammatory phase of scleroderma is the use of immunosuppressive therapy.
The rationale is that an autoimmune process is causing the inflammation and the downstream result is tissue damage and
fibrosis. In this model, the fibrosis is an “innocent bystander” that is driven by the cytokines (chemical messengers) pro-
duced by the immune system. There are several drugs that are being used, but only a few well designed studies have been
performed. These immunosuppressing drugs include methotrexate, cyclosporine, antithymocyte globulin, mycophenolate
mofetil and cyclophosphamide. A recent study suggested that methotrexate did not significantly alter the skin score (a meas-
ure of skin thickening) compared with placebo (no treatment). Cyclosporine is not completely studied due to reports of
renal toxicity. The most promising drugs are mycophenolate mofetil or cyclophosphamide with or without antithymocyte
globulin. Unfortunately, there is no placebo-controlled study (i.e., half the patients get the medication and half get a sugar
pill) to define their exact role in treating scleroderma, but if used during the active inflammatory phase of the disease, they
appear to work. A major area of current research is the use of aggressive immunosuppressive therapy either with very-high-
dose cyclophosphamide or with autologous bone marrow transplantation. Because these aggressive forms of immunosup-
pressive therapy have potential risks, they should be used in severe cases of scleroderma and administered as part of a re-
search protocol.’
For a more in-depth understanding of the comprehensive care related to scleroderma download Chapter 23 of Systemic Sclerosis (pdf)
by Dr. Laura Hummers and Dr. Fred Wigley, from: ttp://www.hopkinsscleroderma.org/patients/scleroderma-treatment-options
Scleroderma News: Pharmacy Page 20
Break Time
Notice board Local Contacts and support services
Inspirational Quote of the Season “A healthy attitude is contagious but don't wait to catch it from others. Be a carrier.”
- Sir Tom Stoppard, OM, CBE, FRSL, Czech-born British playwright, knighted in 1997.
Bedfordshire
Rita Boulton
01767 312544
Buckinghamshire &
Hertfordshire
Marilyn York
andrewandmarilyn@bt
internet.com 07702 592 387
Burton on Trent
Helen Nutland
[email protected] 01283 566333 x5247
Cornwall
Alex Pooley
alex@sclerodermasociety.
co.uk 01736 755845
Derbyshire, S.Yorkshire,
Staffordshire & Cheshire
Lynette Peters
lynette@sclerodermasociety.
co.uk 07947 350815
Derbyshire, S.Yorkshire,
Staffordshire & Cheshire
Diana Twigg
diana@sclerodermasociety.
co.uk 01298 24539
Devon
Anne Sheere
.co.uk 01752 338156
East Anglia
Jacky March
jacky@sclerodermasociety
.co.uk 01394 286637
East Midlands
Cheryl Darch
cheryl@sclerodermasociety
.co.uk 0116 2717180
East Sussex
Rosanna Clifton
rosanna@sclerodermasociety
.co.uk 01424 426738
East Yorkshire
Lynn Hind
01482 354312
Essex, Kent & East London
Amanda Thorpe
01702 344925
Hampshire
Tracey James
02392 677476
Lancashire & North West
Yorkshire
Sheila Procter
sheila@sclerodermasociety.
co.uk 01282 429004
Merseyside
Helen Lingwood
0151 2801194
North East England
Jessie Pickering
01388 527840
North East Scotland
Susan Wilson
077 40185627
North Wales
Kate Owen
angharad.owen48@btinternet.
com 01492 515834
Oxfordshire & Berkshire
Melanie Bowen
melanie@sclerodermasociety
.co.uk 01865 517033
Powys & Shropshire
Jennifer Ames
01544 267988
Scotland
Frances Bain
0131 477 1122
South London
Celia Bhinda
020 8698 6294
South Wales
Belinda Thompson
belinda@sclerodermasociety
.co.uk 02920 625056
South West England
Judith Foster
07985 335 336
Surrey
Nicky O'Shea
01483 764524
West Midlands
Jane Beach
01527 459552
West Sussex
Lesley Dodd
01903 753971
West Sussex
Jo Frowde
01403 741445
Wiltshire & North Hampshire
Lynn Morton
lynnm@sclerodermasociety
.co.uk 01980 863444
Local Group Co-ordinator: Liz Holloway
[email protected], 01243 539466
Join us on Facebook!
www.facebook.com/
sclerodermauk
Online Support
We have set up a new
and complementary
community powered by
Health Unlocked. If you
are a Facebook user you
may have seen advertise-
ments pop up on your
page. Why not give both
the forums a go? Have a
look around, meet and
get support from other
people with Scleroder-
ma.
Scleroderma News: Local Groups Page 21
Contacts
Steve Holloway
(Secretary) steve@
sclerodermasociety.co.uk
Susie Hoare suzie@
sclerodermasociety.co.uk
Helena Rozga Helena@
sclerodermasociety.co.uk
Office & Administration
Manager: Amy Barrick
020 7000 1925, amy@
sclerodermasociety.co.uk
Local Group co-
ordinator: Liz Holloway,
uk
Helpline Manager: Helena
Rozga, Helena@
sclerodermasociety.co.uk
Event enquiries: Amy
Baker, fundraising@
sclerodermasociety.co.uk
Events Calendar Calendar
@sclerodermasociety.co.uk
Specialist Nurses:
Nurse led lines for general
inquiries only, in non emer-
gencies. If the nurse is una-
vailable please leave a mes-
sage:
Helpline: Although The
Scleroderma Society can
not offer medical advice,
they operate a free helpline,
offering a kind ear. We will
help in any way we can be-
tween 9.00—21.00 every
day. Call 0800 311 2756.
Carers Support Group:
Michael Thorpe 01702 344
925, [email protected]
Liverpool Aintree Univer-
sity Hospital: Jan Lamb
0151 525 5980 bleep 2231
Bath Royal National Hospi-
tal for Rheumatic Diseases:
Sue Brown 01225 428 823
Belfast Ulster Hospital:
Audrey Hamilton 02890
561 310
Dundee Ninewells Hospi-
tal: Steve McSwiggan 01382
383233
Leeds Chapel Allerton
Hospital: Elizabeth Tyas
0113 392 3035
London Royal Free Hospi-
tal Scleroderma queries: 020
783 02326 and Pulmonary
hypertension:
020 7472 6354
London Royal Bromp-
ton Hospital Respiratory
queries: Lucy Pigram
07758 8943175
Manchester Hope
Hospita: Liz Wragg and
Catherine Lambe 0161
206 0192
Newcastle Freeman
Hospital Scleroderma
queries: Karen Walker
0191 223 1503 and
Pulmonary hypertension:
Rachael Crackett /
Julia De Soyza
0191 213 7418
Portsmouth Queen
Alexandra Hospital:
Paula White / Julie In-
gold 02392 286935
Scleroderma News: Contacts Page 22
Connecting you to Scleroderma Professionals,
groups and nation wide support networks
Scleroderma
News
Write to:
The Scleroderma Society
Bride House,
18-20 Bride Lane,
London
EC4Y 8EE
Phone us:
020 7000 1925
Email the editor:
Hollie@Scleroderma
society.co.uk
Proof Reading:
Rosemary Goodwin
Printing & Publishing:
Jarvis & Company
The Scleroderma Society is a registered charity: 286736